Industry
Medical - Devices
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Loading...
Open
19.21
Mkt cap
1.6B
Volume
1.3M
High
19.68
P/E Ratio
10.51
52-wk high
26.80
Low
19.13
Div yield
N/A
52-wk low
14.87
Portfolio Pulse from Avi Kapoor
September 10, 2024 | 2:07 pm
Portfolio Pulse from Benzinga Newsdesk
September 10, 2024 | 11:03 am
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 11:38 am
Portfolio Pulse from Benzinga Newsdesk
August 20, 2024 | 11:37 am
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 7:38 pm
Portfolio Pulse from Benzinga Newsdesk
August 01, 2024 | 11:05 am
Portfolio Pulse from Benzinga Newsdesk
July 23, 2024 | 10:39 am
Portfolio Pulse from Benzinga Newsdesk
July 17, 2024 | 12:05 pm
Portfolio Pulse from Benzinga Newsdesk
July 15, 2024 | 12:58 pm
Portfolio Pulse from Benzinga Newsdesk
May 03, 2024 | 10:17 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.